{
    "xml": "<topic id=\"PHP2596\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/aspirin\" basename=\"aspirin\" title=\"ASPIRIN\">\n<title>ASPIRIN</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_361\" namespace=\"/interactions/list-of-drug-interactions/analgesics/aspirin\">Aspirin</xref>\n</p>\n<data name=\"vtmid\">7947003</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_904822154\" title=\"Salicylates\">Salicylates</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">  </data>\r\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n<p outputclass=\"synonyms\">Acetylsalicylic Acid</p>\r\n</body>\n<topic id=\"PHP62325\" outputclass=\"indicationsAndDose\" rev=\"1.19\" parent=\"/drugs/aspirin\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Cardiovascular disease (secondary prevention)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>75&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Management of unstable angina and non-ST-segment elevation myocardial infarction (NSTEMI)</p>\n<p outputclass=\"therapeuticIndication\">Management of ST-segment elevation myocardial infarction (STEMI)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>300&#8239;mg.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Suspected transient ischaemic attack</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>300&#8239;mg daily until diagnosis established.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Transient ischaemic attack (long-term treatment following in combination with dipyridamole)</p>\n<p outputclass=\"therapeuticIndication\">Ischaemic stroke not associated with atrial fibrillation (in combination with dipyridamole if clopidogrel contraindicated or not tolerated)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>75&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Acute ischaemic stroke</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>300&#8239;mg daily for 14 days, to be initiated 24 hours after thrombolysis or as soon as possible within 48 hours of symptom onset in patients not receiving thrombolysis.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Atrial fibrillation following a disabling ischaemic stroke</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>300&#8239;mg daily for 14 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Following disabling ischaemic stroke in patients receiving anticoagulation for a prosthetic heart valve</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>300&#8239;mg daily, anticoagulant treatment stopped for 7 days and to be substituted with aspirin.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Following coronary by-pass surgery</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>75&#8211;300&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Mild to moderate pain</p>\n<p outputclass=\"therapeuticIndication\">Pyrexia</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>300&#8211;900&#8239;mg every 4&#8211;6&#8239;hours as required; maximum 4&#8239;g per day.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By rectum</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>450&#8211;900&#8239;mg every 4&#8239;hours; maximum 3.6&#8239;g per day.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62447\" outputclass=\"contraindications\" rev=\"1.27\" parent=\"/drugs/aspirin\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Active peptic ulceration</ph>; <ph outputclass=\"contraindication\">bleeding disorders (antiplatelet dose)</ph>; <ph outputclass=\"contraindication\">children under 16 years (risk of Reye&#8217;s syndrome)</ph>; <ph outputclass=\"contraindication\">haemophilia</ph>; <ph outputclass=\"contraindication\">previous peptic ulceration (analgesic dose)</ph>; <ph outputclass=\"contraindication\">severe cardiac failure (analgesic dose)</ph>\n</p>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Contra-indications, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Reye&#8217;s syndrome</p>\n<p>Owing to an association with Reye&#8217;s syndrome, aspirin-containing preparations should not be given to children under 16 years, unless specifically indicated, e.g. for Kawasaki disease.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62467\" outputclass=\"cautions\" rev=\"1.12\" parent=\"/drugs/aspirin\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Allergic disease</ph>; <ph outputclass=\"caution\">anaemia</ph>; <ph outputclass=\"caution\">asthma</ph>; <ph outputclass=\"caution\">dehydration</ph>; <ph outputclass=\"caution\">elderly</ph>; <ph outputclass=\"caution\">G6PD deficiency</ph>; <ph outputclass=\"caution\">preferably avoid during fever or viral infection in children (risk of Reye&#8217;s syndrome)</ph>; <ph outputclass=\"caution\">previous peptic ulceration (but manufacturers may advise avoidance of low-dose aspirin in history of peptic ulceration)</ph>; <ph outputclass=\"caution\">thyrotoxicosis</ph>; <ph outputclass=\"caution\">uncontrolled hypertension</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62292\" outputclass=\"interactions\" rev=\"1.7\" parent=\"/drugs/aspirin\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (aspirin).</p>\n<p>Caution with concomitant use of drugs that increase risk of bleeding.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62151\" outputclass=\"sideEffects\" rev=\"1.23\" parent=\"/drugs/aspirin\">\n<title>Side-effects</title>\n<body>\r\n<section outputclass=\"generalSideEffects\">\r\n<sectiondiv outputclass=\"frequencies\">\r\n\r\n\r\n\r\n\r\n<sectiondiv outputclass=\"notKnown\">\r\n<p outputclass=\"title\">Frequency not known</p>\r\n<p outputclass=\"sideEffects\">\r\n<ph outputclass=\"sideEffect\">Blood disorders (with analgesic doses)</ph>; <ph outputclass=\"sideEffect\">bronchospasm</ph>; <ph outputclass=\"sideEffect\">confusion (with analgesic doses)</ph>; <ph outputclass=\"sideEffect\">gastro-intestinal haemorrhage (occasionally major)</ph>; <ph outputclass=\"sideEffect\">gastro-intestinal irritation (with slight asymptomatic blood loss at higher doses)</ph>; <ph outputclass=\"sideEffect\">haemorrhage including subconjunctival haemorrhage (reported with antiplatelet doses)</ph>; <ph outputclass=\"sideEffect\">increased bleeding time</ph>; <ph outputclass=\"sideEffect\">skin reactions in hypersensitive patients</ph>; <ph outputclass=\"sideEffect\">tinnitus (with analgesic doses)</ph>\r\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\r\n\r\n\r\n<section outputclass=\"sideEffectsOverdosageInformation\">\r\n<title>Overdose</title>\r\n<sectiondiv>\r\n<p>The main features of salicylate poisoning are hyperventilation, tinnitus, deafness, vasodilatation, and sweating. Coma is uncommon but indicates very severe poisoning.</p>\r\n<p>For specific details on the management of poisoning, see <i>Aspirin</i>, under <xref format=\"dita\" href=\"#PHP78558\" type=\"bookmark\" namespace=\"/treatment-summaries/emergency-treatment-of-poisoning\">Emergency treatment of poisoning</xref>.</p>\n</sectiondiv>\n</section>\r\n</body>\n</topic>\n<topic id=\"PHP62494\" outputclass=\"allergyAndCrossSensitivity\" rev=\"1.20\" parent=\"/drugs/aspirin\">\n<title>Allergy and cross-sensitivity</title>\n<body>\n<section outputclass=\"allergyAndCrossSensitivityContraindications\">\n<sectiondiv>\n<p>Aspirin is <b>contraindicated</b> in history of hypersensitivity to aspirin or any other NSAID&#8212;which includes those in whom attacks of asthma, angioedema, urticaria, or rhinitis have been precipitated by aspirin or any other NSAID.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62277\" outputclass=\"pregnancy\" parent=\"/drugs/aspirin\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use antiplatelet doses with caution during third trimester; impaired platelet function and risk of haemorrhage; delayed onset and increased duration of labour with increased blood loss; avoid analgesic doses if possible in last few weeks (low doses probably not harmful); high doses may be related to intrauterine growth restriction, teratogenic effects, closure of fetal ductus arteriosus in utero and possibly persistent pulmonary hypertension of newborn; kernicterus may occur in jaundiced neonates.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62480\" outputclass=\"breastFeeding\" parent=\"/drugs/aspirin\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid&#8212;possible risk of Reye&#8217;s syndrome; regular use of high doses could impair platelet function and produce hypoprothrombinaemia in infant if neonatal vitamin K stores low.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62389\" outputclass=\"hepaticImpairment\" parent=\"/drugs/aspirin\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid in severe impairment&#8212;increased risk of gastro-intestinal bleeding.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62220\" outputclass=\"renalImpairment\" parent=\"/drugs/aspirin\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution; avoid in severe impairment; sodium and water retention; deterioration in renal function; increased risk of gastro-intestinal bleeding.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57493\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.17\" parent=\"/drugs/aspirin\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>BP directs that when no strength is stated the 300&#8239;mg strength should be dispensed, and that when soluble aspirin tablets are prescribed, dispersible aspirin tablets shall be dispensed.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62027\" outputclass=\"professionSpecificInformation\" rev=\"1.10\" parent=\"/drugs/aspirin\">\n<title>Profession specific information</title>\n<body>\n<section outputclass=\"dentalPractitionersFormulary\">\n<title>Dental practitioners' formulary</title>\n<sectiondiv>\n<p>Aspirin Dispersible Tablets 300&#8239;mg may be prescribed.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP62013\" outputclass=\"exceptionsToLegalCategory\" rev=\"1.15\" parent=\"/drugs/aspirin\">\n<title>Exceptions to legal category</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use</p>\n<p>Can be sold to the public provided packs contain no more than 32 capsules or tablets; pharmacists can sell multiple packs up to a total quantity of 100 capsules or tablets in justifiable circumstances.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP2596-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/aspirin\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension, oral solution, powder, capsule, liquid</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77434\" title=\"Tablet\" namespace=\"/drugs/aspirin/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77423\" title=\"Dispersible tablet\" namespace=\"/drugs/aspirin/dispersible-tablet\">Dispersible tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77471\" title=\"Effervescent tablet\" namespace=\"/drugs/aspirin/effervescent-tablet\">Effervescent tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77464\" title=\"Orodispersible tablet\" namespace=\"/drugs/aspirin/orodispersible-tablet\">Orodispersible tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77441\" title=\"Gastro-resistant tablet\" namespace=\"/drugs/aspirin/gastro-resistant-tablet\">Gastro-resistant tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85573\" namespace=\"/drugs/aspirin-with-codeine\" title=\"ASPIRIN WITH CODEINE\" count=\"1\" rel=\"backlink\">ASPIRIN WITH CODEINE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85574\" namespace=\"/drugs/aspirin-with-dipyridamole\" title=\"ASPIRIN WITH DIPYRIDAMOLE\" count=\"1\" rel=\"backlink\">ASPIRIN WITH DIPYRIDAMOLE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85575\" namespace=\"/drugs/aspirin-with-metoclopramide\" title=\"ASPIRIN WITH METOCLOPRAMIDE\" count=\"1\" rel=\"backlink\">ASPIRIN WITH METOCLOPRAMIDE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP97237\" namespace=\"/guidance/adverse-reactions-to-drugs\" title=\"Adverse reactions to drugs\" count=\"1\" rel=\"backlink\">Adverse reactions to drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP98619\" namespace=\"/guidance/prescribing-in-dental-practice\" title=\"Prescribing in dental practice\" count=\"2\" rel=\"backlink\">Prescribing in dental practice</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78099\" namespace=\"/treatment-summaries/hypertension\" title=\"Hypertension\" count=\"6\" rel=\"backlink\">Hypertension</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78110\" namespace=\"/treatment-summaries/-st-segment-elevation-medical-emergency\" title=\" ST-segment elevation, medical emergency\" count=\"1\" rel=\"backlink\"> ST-segment elevation, medical emergency</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78126\" namespace=\"/treatment-summaries/-unstable-medical-emergency\" title=\" unstable, medical emergency\" count=\"1\" rel=\"backlink\"> unstable, medical emergency</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78144\" namespace=\"/treatment-summaries/acute-coronary-syndromes\" title=\"Acute coronary syndromes\" count=\"22\" rel=\"backlink\">Acute coronary syndromes</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78166\" namespace=\"/treatment-summaries/diabetes\" title=\"Diabetes\" count=\"1\" rel=\"backlink\">Diabetes</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78168\" namespace=\"/treatment-summaries/management-of-stroke\" title=\"Management of stroke\" count=\"12\" rel=\"backlink\">Management of stroke</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78175\" namespace=\"/treatment-summaries/peripheral-vascular-disease\" title=\"Peripheral vascular disease\" count=\"1\" rel=\"backlink\">Peripheral vascular disease</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78186\" namespace=\"/treatment-summaries/antiplatelet-drugs\" title=\"Antiplatelet drugs\" count=\"16\" rel=\"backlink\">Antiplatelet drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78213\" namespace=\"/treatment-summaries/oral-anticoagulants\" title=\"Oral anticoagulants\" count=\"4\" rel=\"backlink\">Oral anticoagulants</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78238\" namespace=\"/treatment-summaries/migraine\" title=\"Migraine\" count=\"2\" rel=\"backlink\">Migraine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78291\" namespace=\"/treatment-summaries/arrhythmias\" title=\"Arrhythmias\" count=\"2\" rel=\"backlink\">Arrhythmias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78400\" namespace=\"/treatment-summaries/sex-hormones\" title=\"Sex hormones\" count=\"1\" rel=\"backlink\">Sex hormones</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78520\" namespace=\"/treatment-summaries/analgesics\" title=\"Analgesics\" count=\"17\" rel=\"backlink\">Analgesics</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78557\" namespace=\"/treatment-summaries/eye\" title=\"Eye\" count=\"1\" rel=\"backlink\">Eye</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78607\" namespace=\"/treatment-summaries/gout\" title=\"Gout\" count=\"2\" rel=\"backlink\">Gout</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78612\" namespace=\"/treatment-summaries/non-steroidal-anti-inflammatory-drugs\" title=\"Non-steroidal anti-inflammatory drugs\" count=\"1\" rel=\"backlink\">Non-steroidal anti-inflammatory drugs</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_361\" namespace=\"/interactions/list-of-drug-interactions/analgesics/aspirin\" title=\"Aspirin\" count=\"1\" rel=\"link\">Aspirin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78558\" namespace=\"/treatment-summaries/emergency-treatment-of-poisoning\" title=\"Emergency treatment of poisoning\" count=\"1\" rel=\"link\">Emergency treatment of poisoning</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77434\" namespace=\"/drugs/aspirin/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77423\" namespace=\"/drugs/aspirin/dispersible-tablet\" title=\"Dispersible tablet\" count=\"1\" rel=\"link\">Dispersible tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77471\" namespace=\"/drugs/aspirin/effervescent-tablet\" title=\"Effervescent tablet\" count=\"1\" rel=\"link\">Effervescent tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77464\" namespace=\"/drugs/aspirin/orodispersible-tablet\" title=\"Orodispersible tablet\" count=\"1\" rel=\"link\">Orodispersible tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77441\" namespace=\"/drugs/aspirin/gastro-resistant-tablet\" title=\"Gastro-resistant tablet\" count=\"1\" rel=\"link\">Gastro-resistant tablet</xref>\n</links>\n</topic>",
    "id": "PHP2596",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/aspirin",
    "basename": "aspirin",
    "title": "ASPIRIN",
    "interactants": [
        {
            "id": "bnf_int_361",
            "label": "Aspirin"
        }
    ],
    "vtmid": "7947003",
    "drugClassification": [
        "Salicylates"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "synonyms": [
        "Acetylsalicylic Acid"
    ],
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Cardiovascular disease (secondary prevention)",
                        "html": "Cardiovascular disease (secondary prevention)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "75 mg daily.",
                        "html": "<p>75&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Management of unstable angina and non-ST-segment elevation myocardial infarction (NSTEMI)",
                        "html": "Management of unstable angina and non-ST-segment elevation myocardial infarction (NSTEMI)"
                    },
                    {
                        "textContent": "Management of ST-segment elevation myocardial infarction (STEMI)",
                        "html": "Management of ST-segment elevation myocardial infarction (STEMI)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "300 mg.",
                        "html": "<p>300&#8239;mg.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Suspected transient ischaemic attack",
                        "html": "Suspected transient ischaemic attack"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "300 mg daily until diagnosis established.",
                        "html": "<p>300&#8239;mg daily until diagnosis established.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Transient ischaemic attack (long-term treatment following in combination with dipyridamole)",
                        "html": "Transient ischaemic attack (long-term treatment following in combination with dipyridamole)"
                    },
                    {
                        "textContent": "Ischaemic stroke not associated with atrial fibrillation (in combination with dipyridamole if clopidogrel contraindicated or not tolerated)",
                        "html": "Ischaemic stroke not associated with atrial fibrillation (in combination with dipyridamole if clopidogrel contraindicated or not tolerated)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "75 mg daily.",
                        "html": "<p>75&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Acute ischaemic stroke",
                        "html": "Acute ischaemic stroke"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "300 mg daily for 14 days, to be initiated 24 hours after thrombolysis or as soon as possible within 48 hours of symptom onset in patients not receiving thrombolysis.",
                        "html": "<p>300&#8239;mg daily for 14 days, to be initiated 24 hours after thrombolysis or as soon as possible within 48 hours of symptom onset in patients not receiving thrombolysis.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Atrial fibrillation following a disabling ischaemic stroke",
                        "html": "Atrial fibrillation following a disabling ischaemic stroke"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "300 mg daily for 14 days.",
                        "html": "<p>300&#8239;mg daily for 14 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Following disabling ischaemic stroke in patients receiving anticoagulation for a prosthetic heart valve",
                        "html": "Following disabling ischaemic stroke in patients receiving anticoagulation for a prosthetic heart valve"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "300 mg daily, anticoagulant treatment stopped for 7 days and to be substituted with aspirin.",
                        "html": "<p>300&#8239;mg daily, anticoagulant treatment stopped for 7 days and to be substituted with aspirin.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Following coronary by-pass surgery",
                        "html": "Following coronary by-pass surgery"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "75&#8211;300 mg daily.",
                        "html": "<p>75&#8211;300&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Mild to moderate pain",
                        "html": "Mild to moderate pain"
                    },
                    {
                        "textContent": "Pyrexia",
                        "html": "Pyrexia"
                    }
                ],
                "specificity": {
                    "routes": [
                        "rectum"
                    ],
                    "textContent": "By rectum",
                    "html": "By rectum"
                },
                "adult": [
                    {
                        "textContent": "300&#8211;900 mg every 4&#8211;6 hours as required; maximum 4 g per day.",
                        "html": "<p>300&#8211;900&#8239;mg every 4&#8211;6&#8239;hours as required; maximum 4&#8239;g per day.</p>"
                    },
                    {
                        "textContent": "450&#8211;900 mg every 4 hours; maximum 3.6 g per day.",
                        "html": "<p>450&#8211;900&#8239;mg every 4&#8239;hours; maximum 3.6&#8239;g per day.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Active peptic ulceration",
                "html": "Active peptic ulceration"
            },
            {
                "type": "contraindications",
                "textContent": "bleeding disorders (antiplatelet dose)",
                "html": "bleeding disorders (antiplatelet dose)"
            },
            {
                "type": "contraindications",
                "textContent": "children under 16 years (risk of Reye&#8217;s syndrome)",
                "html": "children under 16 years (risk of Reye&#8217;s syndrome)"
            },
            {
                "type": "contraindications",
                "textContent": "haemophilia",
                "html": "haemophilia"
            },
            {
                "type": "contraindications",
                "textContent": "previous peptic ulceration (analgesic dose)",
                "html": "previous peptic ulceration (analgesic dose)"
            },
            {
                "type": "contraindications",
                "textContent": "severe cardiac failure (analgesic dose)",
                "html": "severe cardiac failure (analgesic dose)"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "title": "Reye&#8217;s syndrome",
                "textContent": "Owing to an association with Reye&#8217;s syndrome, aspirin-containing preparations should not be given to children under 16 years, unless specifically indicated, e.g. for Kawasaki disease.",
                "html": "<p>Owing to an association with Reye&#8217;s syndrome, aspirin-containing preparations should not be given to children under 16 years, unless specifically indicated, e.g. for Kawasaki disease.</p>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Allergic disease",
                "html": "Allergic disease"
            },
            {
                "type": "cautions",
                "textContent": "anaemia",
                "html": "anaemia"
            },
            {
                "type": "cautions",
                "textContent": "asthma",
                "html": "asthma"
            },
            {
                "type": "cautions",
                "textContent": "dehydration",
                "html": "dehydration"
            },
            {
                "type": "cautions",
                "textContent": "elderly",
                "html": "elderly"
            },
            {
                "type": "cautions",
                "textContent": "G6PD deficiency",
                "html": "G6PD deficiency"
            },
            {
                "type": "cautions",
                "textContent": "preferably avoid during fever or viral infection in children (risk of Reye&#8217;s syndrome)",
                "html": "preferably avoid during fever or viral infection in children (risk of Reye&#8217;s syndrome)"
            },
            {
                "type": "cautions",
                "textContent": "previous peptic ulceration (but manufacturers may advise avoidance of low-dose aspirin in history of peptic ulceration)",
                "html": "previous peptic ulceration (but manufacturers may advise avoidance of low-dose aspirin in history of peptic ulceration)"
            },
            {
                "type": "cautions",
                "textContent": "thyrotoxicosis",
                "html": "thyrotoxicosis"
            },
            {
                "type": "cautions",
                "textContent": "uncontrolled hypertension",
                "html": "uncontrolled hypertension"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (aspirin).\n\nCaution with concomitant use of drugs that increase risk of bleeding.",
                "html": "<p>Appendix 1 (aspirin).</p><p>Caution with concomitant use of drugs that increase risk of bleeding.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Blood disorders (with analgesic doses)",
                        "html": "Blood disorders (with analgesic doses)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "bronchospasm",
                        "html": "bronchospasm",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "confusion (with analgesic doses)",
                        "html": "confusion (with analgesic doses)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "gastro-intestinal haemorrhage (occasionally major)",
                        "html": "gastro-intestinal haemorrhage (occasionally major)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "gastro-intestinal irritation (with slight asymptomatic blood loss at higher doses)",
                        "html": "gastro-intestinal irritation (with slight asymptomatic blood loss at higher doses)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "haemorrhage including subconjunctival haemorrhage (reported with antiplatelet doses)",
                        "html": "haemorrhage including subconjunctival haemorrhage (reported with antiplatelet doses)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "increased bleeding time",
                        "html": "increased bleeding time",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "skin reactions in hypersensitive patients",
                        "html": "skin reactions in hypersensitive patients",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "tinnitus (with analgesic doses)",
                        "html": "tinnitus (with analgesic doses)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "overdosageInformation": [
            {
                "type": "overdosageInformation",
                "references": [
                    {
                        "id": "PHP78558",
                        "label": "Emergency treatment of poisoning"
                    }
                ],
                "textContent": "The main features of salicylate poisoning are hyperventilation, tinnitus, deafness, vasodilatation, and sweating. Coma is uncommon but indicates very severe poisoning.\n\nFor specific details on the management of poisoning, see Aspirin, under Emergency treatment of poisoning.",
                "html": "<p>The main features of salicylate poisoning are hyperventilation, tinnitus, deafness, vasodilatation, and sweating. Coma is uncommon but indicates very severe poisoning.</p><p>For specific details on the management of poisoning, see <i>Aspirin</i>, under <xref format=\"dita\" href=\"#PHP78558\" type=\"bookmark\" namespace=\"/treatment-summaries/emergency-treatment-of-poisoning\">Emergency treatment of poisoning</xref>.</p>"
            }
        ]
    },
    "allergyAndCrossSensitivity": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Aspirin is contraindicated in history of hypersensitivity to aspirin or any other NSAID&#8212;which includes those in whom attacks of asthma, angioedema, urticaria, or rhinitis have been precipitated by aspirin or any other NSAID.",
                "html": "<p>Aspirin is <b>contraindicated</b> in history of hypersensitivity to aspirin or any other NSAID&#8212;which includes those in whom attacks of asthma, angioedema, urticaria, or rhinitis have been precipitated by aspirin or any other NSAID.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use antiplatelet doses with caution during third trimester; impaired platelet function and risk of haemorrhage; delayed onset and increased duration of labour with increased blood loss; avoid analgesic doses if possible in last few weeks (low doses probably not harmful); high doses may be related to intrauterine growth restriction, teratogenic effects, closure of fetal ductus arteriosus in utero and possibly persistent pulmonary hypertension of newborn; kernicterus may occur in jaundiced neonates.",
                "html": "<p>Use antiplatelet doses with caution during third trimester; impaired platelet function and risk of haemorrhage; delayed onset and increased duration of labour with increased blood loss; avoid analgesic doses if possible in last few weeks (low doses probably not harmful); high doses may be related to intrauterine growth restriction, teratogenic effects, closure of fetal ductus arteriosus in utero and possibly persistent pulmonary hypertension of newborn; kernicterus may occur in jaundiced neonates.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid&#8212;possible risk of Reye&#8217;s syndrome; regular use of high doses could impair platelet function and produce hypoprothrombinaemia in infant if neonatal vitamin K stores low.",
                "html": "<p>Avoid&#8212;possible risk of Reye&#8217;s syndrome; regular use of high doses could impair platelet function and produce hypoprothrombinaemia in infant if neonatal vitamin K stores low.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid in severe impairment&#8212;increased risk of gastro-intestinal bleeding.",
                "html": "<p>Avoid in severe impairment&#8212;increased risk of gastro-intestinal bleeding.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution; avoid in severe impairment; sodium and water retention; deterioration in renal function; increased risk of gastro-intestinal bleeding.",
                "html": "<p>Use with caution; avoid in severe impairment; sodium and water retention; deterioration in renal function; increased risk of gastro-intestinal bleeding.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "BP directs that when no strength is stated the 300 mg strength should be dispensed, and that when soluble aspirin tablets are prescribed, dispersible aspirin tablets shall be dispensed.",
                "html": "<p>BP directs that when no strength is stated the 300&#8239;mg strength should be dispensed, and that when soluble aspirin tablets are prescribed, dispersible aspirin tablets shall be dispensed.</p>"
            }
        ]
    },
    "professionSpecificInformation": {
        "dentalPractitionersFormulary": [
            {
                "type": "dentalPractitionersFormulary",
                "textContent": "Aspirin Dispersible Tablets 300 mg may be prescribed.",
                "html": "<p>Aspirin Dispersible Tablets 300&#8239;mg may be prescribed.</p>"
            }
        ]
    },
    "exceptionsToLegalCategory": {
        "exceptionsToLegalCategory": [
            {
                "type": "exceptionsToLegalCategory",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With <ph outputclass=\"route\">oral</ph> use",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Can be sold to the public provided packs contain no more than 32 capsules or tablets; pharmacists can sell multiple packs up to a total quantity of 100 capsules or tablets in justifiable circumstances.",
                "html": "<p>Can be sold to the public provided packs contain no more than 32 capsules or tablets; pharmacists can sell multiple packs up to a total quantity of 100 capsules or tablets in justifiable circumstances.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension",
                "oral solution",
                "powder",
                "capsule",
                "liquid"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77434",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77423",
                "label": "Dispersible tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77471",
                "label": "Effervescent tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77464",
                "label": "Orodispersible tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77441",
                "label": "Gastro-resistant tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP85573",
                "label": "ASPIRIN WITH CODEINE",
                "type": "drug"
            },
            {
                "id": "PHP85574",
                "label": "ASPIRIN WITH DIPYRIDAMOLE",
                "type": "drug"
            },
            {
                "id": "PHP85575",
                "label": "ASPIRIN WITH METOCLOPRAMIDE",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP97237",
                "label": "Adverse reactions to drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP98619",
                "label": "Prescribing in dental practice",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78099",
                "label": "Hypertension",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78110",
                "label": "ST-segment elevation, medical emergency",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78126",
                "label": "unstable, medical emergency",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78144",
                "label": "Acute coronary syndromes",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78166",
                "label": "Diabetes",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78168",
                "label": "Management of stroke",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78175",
                "label": "Peripheral vascular disease",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78186",
                "label": "Antiplatelet drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78213",
                "label": "Oral anticoagulants",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78238",
                "label": "Migraine",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78291",
                "label": "Arrhythmias",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78400",
                "label": "Sex hormones",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78520",
                "label": "Analgesics",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78557",
                "label": "Eye",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78607",
                "label": "Gout",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78612",
                "label": "Non-steroidal anti-inflammatory drugs",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_361",
                "label": "Aspirin",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78558",
                "label": "Emergency treatment of poisoning",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77434",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77423",
                "label": "Dispersible tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77471",
                "label": "Effervescent tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77464",
                "label": "Orodispersible tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77441",
                "label": "Gastro-resistant tablet",
                "type": "medicinalForm"
            }
        ]
    }
}